Kantify
Business Services · Belgium · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Ave Louise 54, Bruxelles Ixelles, Brusse...Phone Number
+32 28084877Website
www.kantify.comRevenue
<$5 MillionIndustry
About Kantify
Is Kantify your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Kantify recently announced quarterly report
Kantify, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Kantify has new funding data
Check if Kantify has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Kantify launches new products
Check out if Kantify is spiking on competitors!
Click to see if Kantify had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Kantify
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Kantify as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Kantify is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Kantify is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Kantify.
Kantify Tech Stack
A closer look at the technologies used by Kantify
Kantify News & Media
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kantify
Kantify specializes in leveraging Artificial Intelligence to discover innovative therapies that significantly improve patient health. Their proprietary AI platform, Sapian, rapidly identifies safe and effective drugs across various diseases, addressing the urgent need for more therapy options. With a focus on small molecule drugs and targeted prote... Read More